- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05330546
Evaluation of Implant Stability in Low Quality Bone Following the Use of Osseodensifiers Versus Ridge Expanders
November 16, 2024 updated by: Mariam Samir Nabih, Cairo University
Evaluation of the Stability of Implants Placed in Low Quality Bone Following the Use of Osseodensification Technique Versus Ridge Expanders: Randomized Clinical Trial
the use of osseodensification technique compared to ridge expansion screws in low bone quality
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
using Densah burs in preparation of implant osteotomy compared to ridge expansion screws in low quality bone
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
• Single tooth missing in the maxillary region with D3 (350-850 HU) and D4 (150-350 HU) bone (Sultana et al., 2020).
A minimum of 4 mm residual buccolingual bone width at site of implant placement (Koutouzis et al., 2019).
- The recipient site of the implant should be free from any pathological conditions.
- No diagnosed bone disease or medication known to affect bone metabolism.
- Patients who are cooperative, motivated and hygiene conscious.
- Patients having adequate inter-occlusal space of 8-10 mm (Fernández et al., 2017)
Exclusion Criteria:
Systemic conditions/diseases that contraindicate surgery (Jarikian et al., 2021).
- Patients who have any habits that might jeopardize the osseointegration process, such as current smokers (Vollmer et al., 2020).
- Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching (Sultana et al., 2020).
- Alcohol or drug abuse (Ibrahim et al., 2020).
- Pregnant and lactating women.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Osseodensification technique group
10 patients will be randomly assigned to the osseodensification group so the implant osteotomy will be prepared using densah burs
|
using Densah burs to prepare implant osteotomy
|
|
Active Comparator: Ridge expansion screw group
10 patients will be randomly assigned to the ridge expansion screw group so the implant osteotomy will be prepared using ridge expansion screws
|
using Ridge expansion screws to prepare implant osteotomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implant stability
Time Frame: change from baseline at 3 month
|
assessing the stability using Osstell
|
change from baseline at 3 month
|
|
Implant stability
Time Frame: change from baseline at 6 month
|
assessing the stability using Osstell
|
change from baseline at 6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic bone density
Time Frame: change from baseline at 3 month
|
using CBCT in mm
|
change from baseline at 3 month
|
|
Radiographic bone density
Time Frame: change from baseline at 6 month
|
using CBCT in mm
|
change from baseline at 6 month
|
|
Change in crestal bone level
Time Frame: change from baseline at 3 month
|
using CBCT in mm
|
change from baseline at 3 month
|
|
Change in crestal bone level
Time Frame: change from baseline at 6 month
|
using CBCT in mm
|
change from baseline at 6 month
|
|
Change in buccolingual bone width
Time Frame: change from baseline at 3 month
|
using CBCT in mm
|
change from baseline at 3 month
|
|
Change in buccolingual bone width
Time Frame: change from baseline at 6 month
|
using CBCT in mm
|
change from baseline at 6 month
|
|
Patient reported outcomes
Time Frame: at time of surgery
|
10 mm Visual analogue scale from 1 to 10 with 1 minimal pain and 10 worst pain experience
|
at time of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed El Barbary, Assis. prof., main supervisor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2022
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
June 30, 2024
Study Registration Dates
First Submitted
April 2, 2022
First Submitted That Met QC Criteria
April 10, 2022
First Posted (Actual)
April 15, 2022
Study Record Updates
Last Update Posted (Estimated)
November 19, 2024
Last Update Submitted That Met QC Criteria
November 16, 2024
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12722
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
raw data will be shared upon request
IPD Sharing Time Frame
upon request for 2 days
IPD Sharing Access Criteria
file including the raw data
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Bone Density
-
Future University in EgyptCompleted
-
Al-Azhar UniversityCompleted
-
Yale UniversityNational Institute on Aging (NIA)CompletedLow Bone DensityUnited States
-
16 Bit Inc.Sunnybrook Health Sciences Centre; AmgenCompleted
-
AmgenCompletedOsteoporosis | Osteopenia | Low Bone Mineral Density | Low Bone Mass | Males With Osteoporosis
-
AmgenCompletedOsteoporosis | Postmenopausal Osteoporosis | Low Bone Mineral Density | Low Bone Mass
-
AmgenCompletedOsteoporosis | Postmenopausal Osteoporosis | Low Bone Mineral Density | Low Bone Mass
-
AmgenCompleted
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedOsteoporosis | Low Bone DensityUnited States
-
Bone Health Technologies, Inc.National Institute on Aging (NIA); University of California, San Francisco; University...CompletedOsteopenia | Low Bone DensityUnited States
Clinical Trials on Densah burs
-
University of Dublin, Trinity CollegeRecruiting
-
Hams Hamed AbdelrahmanCompletedDental Implant | OsseodensificationEgypt
-
University of BaghdadCompleted
-
Cairo UniversityCompleted
-
University of BaghdadActive, not recruitingEdentulous Alveolar RidgeIraq
-
Cairo UniversityUnknown
-
Mansoura UniversityCompleted
-
Faculty of Dental Medicine for GirlsCompletedLaser Effect Around Dental Implant | Implant Stability and OsseointegrationEgypt
-
Suez Canal UniversityNot yet recruitingPatient With Low Denisty Bone
-
Cairo UniversityUnknownImplant Tissue FailureEgypt